BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
12.16
+0.31 (2.62%)
At close: Oct 20, 2025, 4:00 PM EDT
12.14
-0.02 (-0.16%)
After-hours: Oct 20, 2025, 4:10 PM EDT

BriaCell Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Oct '25 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21 2016 - 2020
22131410610179
Upgrade
Market Cap Growth
19.86%-6.05%-87.19%4.90%29.07%1427.04%
Upgrade
Enterprise Value
4-012775759
Upgrade
Last Close Price
11.857.46112.871003.50975.00762.00
Upgrade
PB Ratio
1.280.74-5.08-28.189.822.84
Upgrade
P/TBV Ratio
1.250.72--10.052.87
Upgrade
Debt / Equity Ratio
-----0.00
Upgrade
Quick Ratio
4.494.490.2111.8043.64102.88
Upgrade
Current Ratio
5.015.010.4914.9645.00103.81
Upgrade
Return on Equity (ROE)
-362.56%-362.56%--619.75%-141.25%-114.78%
Upgrade
Return on Assets (ROA)
-123.56%-123.56%-126.11%-41.71%-18.99%-14.89%
Upgrade
Return on Capital (ROIC)
-232.14%-232.14%--444.01%-50.26%-35.58%
Upgrade
Earnings Yield
-118.66%-205.42%-35.14%-19.08%-26.45%-17.58%
Upgrade
FCF Yield
-127.04%-219.93%-180.31%-22.31%-12.30%-9.86%
Upgrade
Buyback Yield / Dilution
-285.70%-285.70%-5.35%-0.81%-242.82%-
Upgrade
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q